<DOC>
	<DOC>NCT00385658</DOC>
	<brief_summary>This study will investigate the effects of the combination of fluvastatin and fenofibrate on dyslipidemia in comparison to the combination of simvastatin and ezetimibe.</brief_summary>
	<brief_title>Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Written informed consent to participate in the study prior to any study procedures. Male or female subjects, age between 1875 years inclusive. All women of child bearing potential must have a negative pregnancy test Metabolic Syndrome according to the International Diabetes Federation definition: Low plasma HDLC (Men &lt; 40 mg/dl ; Women &lt; 50 mg/dl ). Elevated waist circumference (men ≥ 94 cm, women ≥ 80cm) And one or more of the following criteria: Triglycerides ≥ 150 mg/d.l Raised blood pressure (DBP ≥ 85 mmHg and/or SBP ≥ 130mmHg ) or treated hypertension. Fasting plasma glucose≥ 100mg/dl. Previously diagnosed type 2 diabetes. Dyslipidemia secondary to other causes such as nephrotic syndrome, autoimmune disease. Type 1 diabetes. HbA1c &gt; 9.5%. Unexplained serum creatine phosphokinase &gt; 2 x Upper limit of normal. History of myocardial infarction and/or cerebral stroke and/or unstable angina pectoris. Known or suspected contraindications and warnings according to the country specific label for the investigational drugs. Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Dyslipidemia</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>fluvastatin</keyword>
	<keyword>fenofibrate</keyword>
	<keyword>simvastatin</keyword>
	<keyword>ezetimibe</keyword>
</DOC>